The staked Injective ETF is no longer just approved. It launched on Nasdaq.

• Nasdaq listed the Canary Staked INJ ETF under the ticker INJC effective November 5, 2026
• The fund expects to stake at least 90% of its INJ under normal circumstances and charges a 1.10% annual sponsor fee
• Flow Traders is the lead market maker and BitGo is the custodian

Why it matters: Trading has now started, so US brokerage-account investors can get exposure to INJ plus staking rewards without running validators themselves.
Source: Nasdaq Trader alert
Not financial advice.

💬 Will staking ETFs pull more traditional investors into altcoins? Tell us below.

$INJ #Injective #ETF